Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141009019470N106Phase 3Completed
Phase 3, double-blind trial of ondansetron and ephedrine in hypotension (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Hemodynamic changes, Nausea and vomiting and 1 more. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141009019470N106.